Revised forecast
Fiscal year ending March 2026 · Full yearPrevious forecast published 15 May 2025The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.
Consolidated net sales exceeded the forecast due to the steady performance of the education business, contributions from 薬師スタジオ and New York Joe Exchange, earlier deliveries following the establishment of the new sales management system, improved profitability in the beauty business, and the recovery of the Life Plus business. On the profit side, acquisition-related expenses of ¥93 million associated with the M&A of 3 new subsidiaries, increased amortization of goodwill, impairment losses on fixed assets of ¥32 million, and the reversal of ¥11 million in deferred tax assets reduced profit. On a non-consolidated basis, the recovery of the traditional clothing and jewelry business and the Life Plus business, the absorption-type merger of Yamano Plus, and the steady performance of the beauty business were cited as the reasons for higher sales and profits.
Impairment losses on fixed assets of ¥32 million. The reversal of ¥11 million in deferred tax assets was also recorded.
| Item | Details |
|---|---|
| Net Sales | ¥14,400 million → ¥14,724 million（+2.3%） |
| Operating profit | ¥500 million → ¥411 million（-17.6%） |
| Ordinary income | ¥450 million → ¥360 million（-19.8%） |
| Profit attributable to owners of the parent | ¥320 million → ¥207 million（-35.1%） |
| Net income per share | 9.18 yen → 5.96 yen |
| Fiscal Period Covered | Fiscal year ending March 2026 |
| Period Covered | Full year |
| Publication date of previous forecast | 15 May 2025 |
| Previous-period results | Consolidated: net sales of ¥13,964 million, EBITDA of ¥368 million, operating profit of ¥256 million, ordinary profit of ¥236 million, net income attributable to owners of the parent of ¥41 million, and net income per share of ¥1.20. Non-consolidated: net sales of ¥7,232 million, operating profit of ¥203 million, ordinary profit of ¥176 million, net income of a ¥144 million loss, and net income per share of a ¥4.13 loss. |
| Reason for the revision | Consolidated net sales exceeded the forecast due to the steady performance of the education business, contributions from 薬師スタジオ and New York Joe Exchange, earlier deliveries following the establishment of the new sales management system, improved profitability in the beauty business, and the recovery of the Life Plus business. On the profit side, acquisition-related expenses of ¥93 million associated with the M&A of 3 new subsidiaries, increased amortization of goodwill, impairment losses on fixed assets of ¥32 million, and the reversal of ¥11 million in deferred tax assets reduced profit. On a non-consolidated basis, the recovery of the traditional clothing and jewelry business and the Life Plus business, the absorption-type merger of Yamano Plus, and the steady performance of the beauty business were cited as the reasons for higher sales and profits. |
| Details and amount of extraordinary loss | Impairment losses on fixed assets of ¥32 million. The reversal of ¥11 million in deferred tax assets was also recorded. |
| Consolidated / non-consolidated | Consolidated/non-consolidated |
Items this document does not state (1)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Consolidated net sales exceeded the forecast due to the steady performance of the education business, contributions from the performance of subsidiaries newly added to the Group, earlier deliveries following the establishment of the new sales management system, improved profitability in the beauty business, and the recovery of the Life Plus business. On the profit side, acquisition-related expenses of ¥93 million associated with making subsidiaries part of the Group and increased amortization of goodwill were incurred, along with impairment losses on fixed assets of ¥32 million and the reversal of ¥11 million in deferred tax assets.